Beiersdorf announced the launch of its new skincare approach to acne-prone skin with DERMOPURE CLINICAL PROBIOM8. Rather than broadly targeting bacteria, the product’s patented cosmetic active ingredient uses viable skin-native probiotics to support a balanced skin microbiome.
The approach of Viable skin-native probiotics, builds on more than two decades of microbiome research. Beiersdorf presents the work as drawing on years of research to address one of the world’s most common skin care needs.
At the heart of the approach is the patented cosmetic active ingredient TopiC.A™, which contains two viable, skin-native bacterial strains in dormant state. Activated as part of the PROBIOM8 routine, these probiotics support a balanced skin microbiome. Many existing skin care solutions target microorganisms broadly. TopiC.A™ instead uses carefully selected bacterial strains that occur naturally on healthy-looking skin.
